☰

Amy R. Dunn, B.S. - Publications

Affiliations: 
Emory University, Atlanta, GA 
 The Jackson Laboratory, Bar Harbor, ME, United States 

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Vecchio LM, Sullivan P, Dunn AR, Bermejo MK, Fu R, Masoud ST, Gregersen E, Urs NM, Nazari R, Jensen PH, Ramsey A, Goldstein DS, Miller GW, Salahpour A. Enhanced tyrosine hydroxylase activity induces oxidative stress, causes accumulation of autotoxic catecholamine metabolites, and augments amphetamine effects in vivo. Journal of Neurochemistry. PMID 33991113 DOI: 10.1111/jnc.15432  0.566
2020 McQuail JA, Dunn AR, Stern Y, Barnes CA, Kempermann G, Rapp PR, Kaczorowski CC, Foster TC. Cognitive Reserve in Model Systems for Mechanistic Discovery: The Importance of Longitudinal Studies. Frontiers in Aging Neuroscience. 12: 607685. PMID 33551788 DOI: 10.3389/fnagi.2020.607685  0.617
2020 Dunn AR, Hadad N, Neuner SM, Zhang JG, Philip VM, Dumitrescu L, Hohman TJ, Herskowitz JH, O'Connell KMS, Kaczorowski CC. Identifying Mechanisms of Normal Cognitive Aging Using a Novel Mouse Genetic Reference Panel. Frontiers in Cell and Developmental Biology. 8: 562662. PMID 33042997 DOI: 10.3389/Fcell.2020.562662  0.745
2019 Dunn AR, Kaczorowski CC. Regulation of intrinsic excitability: Roles for learning and memory, aging and Alzheimer's disease, and genetic diversity. Neurobiology of Learning and Memory. 107069. PMID 31442579 DOI: 10.1016/J.Nlm.2019.107069  0.666
2019 Stout K, Dunn A, Hoffman C, Miller GW. The synaptic vesicle glycoprotein 2: structure, function, and disease relevance. Acs Chemical Neuroscience. PMID 31394034 DOI: 10.1021/Acschemneuro.9B00351  0.78
2019 O'Connell KMS, Ouellette AR, Neuner SM, Dunn AR, Kaczorowski CC. Genetic background modifies CNS-mediated sensorimotor decline in the AD-BXD mouse model of genetic diversity in Alzheimer's disease. Genes, Brain, and Behavior. e12603. PMID 31381246 DOI: 10.1111/Gbb.12603  0.756
2019 Dunn AR, O'Connell KMS, Kaczorowski CC. Gene-by-environment interactions in Alzheimer's disease and Parkinson's disease. Neuroscience and Biobehavioral Reviews. PMID 31207254 DOI: 10.1016/J.Neubiorev.2019.06.018  0.659
2019 Dunn AR, Ouellette AR, Neuner SM, Zhang J, Philip V, O'Connell K, Kaczorowski CC. P4-088: GENE-BY-ENVIRONMENT REGULATION OF ALZHEIMER'S DISEASE PATHOGENESIS Alzheimer's & Dementia. 15: P1308-P1308. DOI: 10.1016/J.Jalz.2019.06.3748  0.76
2019 Kaczorowski CC, Dunn AR, Neuner SM, Kumar V, O'Connell KM. P2-138: IDENTIFICATION OF SIPA1L1 AS A NOVEL CANDIDATE GENE MEDIATING PRECLINICAL WEIGHT LOSS IN A MOUSE MODEL OF ALZHEIMER'S DISEASE Alzheimer's & Dementia. 15: P625-P625. DOI: 10.1016/J.Jalz.2019.06.2545  0.77
2019 Grudny M, Neuner SM, Dunn AR, Pompilus M, Kaczorowski CC, Febo M. P2-130: BACKGROUND GENETICS IMPACTS MICROSTRUCTURE MEASURES IN MOTOR CORTEX AND HIPPOCAMPUS OF WILDTYPE AND 5XFAD MICE Alzheimer's & Dementia. 15: P622-P622. DOI: 10.1016/J.Jalz.2019.06.2537  0.757
2018 Dunn AR, Neuner SM, Ding S, Hope KA, O'Connell KMS, Kaczorowski CC. Cell-Type-Specific Changes in Intrinsic Excitability in the Subiculum following Learning and Exposure to Novel Environmental Contexts. Eneuro. 5. PMID 30627661 DOI: 10.1523/ENEURO.0484-18.2018  0.748
2018 Bhattacharya S, Ma Y, Dunn AR, Bradner JM, Scimemi A, Miller GW, Traynelis SF, Wichmann T. NMDA receptor blockade ameliorates abnormalities of spike firing of subthalamic nucleus neurons in a parkinsonian nonhuman primate. Journal of Neuroscience Research. PMID 29577359 DOI: 10.1002/Jnr.24230  0.532
2017 Dunn AR, Hoffman CA, Stout KA, Ozawa M, Dhamsania RK, Miller GW. Immunochemical Analysis Of The Expression Of Sv2c In Mouse, Macaque And Human Brain. Brain Research. PMID 29274878 DOI: 10.1016/J.Brainres.2017.12.029  0.798
2017 Dunn AR, Stout KA, Ozawa M, Lohr KM, Hoffman CA, Bernstein AI, Li Y, Wang M, Sgobio C, Sastry N, Cai H, Caudle WM, Miller GW. Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease. Proceedings of the National Academy of Sciences of the United States of America. PMID 28246328 DOI: 10.1073/Pnas.1616892114  0.772
2016 Cliburn RA, Dunn AR, Stout KA, Hoffman CA, Lohr KM, Bernstein AI, Winokur EJ, Burkett J, Shmitz Y, Caudle WM, Miller GW. Immunochemical localization of vesicular monoamine transporter 2 (VMAT2) in mouse brain. Journal of Chemical Neuroanatomy. PMID 27836486 DOI: 10.1016/J.Jchemneu.2016.11.003  0.709
2016 Stout KA, Dunn AR, Lohr KM, Alter SP, Cliburn RA, Guillot TS, Miller GW. Selective enhancement of dopamine release in the ventral pallidum of methamphetamine-sensitized mice. Acs Chemical Neuroscience. PMID 27501345 DOI: 10.1021/Acschemneuro.6B00131  0.729
2016 Lohr KM, Chen M, Hoffman CA, McDaniel MJ, Stout KA, Dunn AR, Wang M, Bernstein A, Miller GW. Vesicular monoamine transporter 2 (VMAT2) level regulates MPTP vulnerability and clearance of excess dopamine in mouse striatal terminals. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 27287315 DOI: 10.1093/Toxsci/Kfw106  0.795
2015 Lohr KM, Stout KA, Dunn AR, Wang M, Salahpour A, Guillot TS, Miller GW. Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity. Acs Chemical Neuroscience. 6: 790-9. PMID 25746685 DOI: 10.1021/Acschemneuro.5B00010  0.814
2014 Lohr KM, Bernstein AI, Stout KA, Dunn AR, Lazo CR, Alter SP, Wang M, Li Y, Fan X, Hess EJ, Yi H, Vecchio LM, Goldstein DS, Guillot TS, Salahpour A, et al. Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo. Proceedings of the National Academy of Sciences of the United States of America. 111: 9977-82. PMID 24979780 DOI: 10.1073/Pnas.1402134111  0.781
2006 Dunn A, Ouellette A, Neuner SM, O'Connell KM, Kaczorowski CC. P1-147: GENE X DIET INTERACTIONS MODIFY SYMPTOMS OF ALZHEIMER'S DISEASE Alzheimer's & Dementia. 14: P332-P333. DOI: 10.1016/J.Jalz.2018.06.150  0.749
2006 O'Connell KM, Dunn A, Ouellette A, Neuner SM, Kaczorowski CC. P3-138: HYPOTHALAMIC ENERGY BALANCE DYSFUNCTION IN THE ETIOLOGY OF ALZHEIMER'S DISEASE Alzheimer's & Dementia. 14: P1121-P1121. DOI: 10.1016/J.Jalz.2018.06.1495  0.757
Show low-probability matches.